Key facts
- Berlin Heals’s last known valuation is $154.9M (Feb 2026).
- It has raised $76.7M; the latest was Later Stage VC ($10.8M) in Feb 2026.
- Notable investors include BLR Partners, Reto Moro.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Berlin Heals
- ·The full record, as it builds
Funding rounds
No funding rounds for Berlin Heals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Berlin Heals
Developer of a cardiac implant device designed for the treatment of heart failure with Electrical Microcurrent. The company offers an electroceutical device for heart failure therapy that can readjust the disturbed myocardial electrical gradient in heart failure patients, enabling patients with systemic and refractory heart failure to get near-curative treatment.
- Sector
- Healthcare
- HQ
- Zug, Switzerland
- Founded
- 2014
- Employees
- 36
- Website
- berlinheals.com/
- Ownership
- Privately Held (backing)
Berlin Heals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Berlin Heals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Berlin Heals in its N-PORT filings yet. We sweep new filings monthly.